Witness Testimony Keywords from Transcript neurodegenerative disease research, spike protein toxicity , blood-brain barrier concerns, lipid nanoparticle distribution, neuroinflammation hypothesis, prion-like Neuropathological concerns regarding mRNA COVID-19 vaccines, spike protein toxicity, and potential long-term He discussed hypotheses regarding spike protein toxicity, neuroinflammation, microglial activation, and potential prion-like or amyloid-forming domains within the spike protein structure.

Testimony Keywords from Transcript virology expertise, viral evolution theory, mRNA platform concerns, spike protein toxicity, lipid nanoparticle delivery, biodistribution issues, immune imprinting hypothesis, novel gene-based platform utilizing lipid nanoparticles to deliver genetic instructions encoding the spike protein. He raised questions about biodistribution, persistence of spike protein expression, and potential unintended

Laderoute focused on the toxic effects of the spike protein, which is known to cause micro-clotting in She indicated that individuals vaccinated with mRNA vaccines could potentially shed the spike protein mortality rates for both vaccinated and unvaccinated individuals following mass vaccination, supporting the hypothesis Corroborating Evidence from the 2023 NCI Report General Findings on Shedding Spike Protein Toxicity : The 2023 NCI Report emphasized the toxic nature of the spike protein, which can lead to micro-clotting

protein effects, mRNA vaccine platform, lipid nanoparticle toxicity, pseudouridine modification, immune Mechanistic critique of mRNA COVID-19 vaccines based on spike protein interaction with the renin-angiotensin protein and the renin-angiotensin system (RAS). He explained that both viral infection and vaccine-induced spike protein production may bind to the ACE2 He argued that certain structural features of the SARS-CoV-2 spike protein, including receptor-binding

protein cytotoxicity, lipid nanoparticle biodistribution, ovarian accumulation concern, clotting pathway dysregulation, amyloidogenic spike peptides, embalmer fibrous clots, double stranded DNA contamination protein toxicity, lipid nanoparticle distribution, and potential genomic and clotting effects. protein toxicity, lipid nanoparticle distribution, DNA contamination, and failures in pharmacovigilance protein production may persist in multiple tissues.

FDA policy change, biodistribution studies absence, pharmacokinetics requirement, lipid nanoparticle toxicity , spike protein persistence, transplacental passage concern, breast milk RNA detection, SV40 promoter mRNA platforms, which involve injection of synthetic genetic material directing host cells to produce spike protein. Her testimony also addressed reported biodistribution of lipid nanoparticles and spike protein throughout

claim, fertility impact allegation, clinical trial audit demand, regulatory malfeasance assertion, spike protein persistence, DNA contamination claim, SV40 promoter concern, spike detox protocol Included in protein mitigation approaches. protein toxicity and persistence. protein, while acknowledging the absence of large randomized trials. 🔎 How to Search the Transcript

Witness Testimony Keywords from Transcript mRNA platform history, lipid nanoparticle inflammation, spike protein toxicity claim, pediatric myocarditis risk, risk-benefit in children, plasmid DNA contamination that he initially viewed COVID-19 genetic vaccines with concern because they encode the SARS-CoV-2 spike protein, which he characterized as biologically active and potentially toxic. plasmid DNA contamination, truncated mRNA transcripts, inadequate purification processes, and unresolved toxicity

complaint, Alain Berset charges, abuse of office allegation, informed consent claim, lipid nanoparticle toxicity claim, spike protein persistence, Dr. Najadi also described undergoing laboratory testing in Germany, which he stated showed persistent spike protein and alleged toxic effects from lipid nanoparticles. involvement in civil litigation filed in New York State against Pfizer, arguing that U.S. constitutional protections

Marian Laderoute Spike Protein Toxicity : Dr. Laderoute discussed the toxic effects of the spike protein and its potential to cause micro-clotting She suggested that the spike protein could be shed by vaccinated individuals, posing health risks to Spike Protein and Shedding : The 2023 NCI Report discussed the potential risks associated with spike protein shedding from vaccinated individuals.

Witness Testimony Keywords from Transcript protein kinase research, spike protein signaling, lipid nanoparticle One Line Summary UBC biomedical scientist analyzes spike protein signaling effects and raises concerns protein. He explained that spike protein is biologically active and capable of interacting with cellular signaling He raised concerns regarding variability in mRNA translation levels, persistence of spike protein expression

Witness Testimony Keywords from Transcript mRNA integrity variation, spike protein isoforms, translation Biochemical critique of mRNA COVID-19 vaccine quality control, spike protein variability, biodistribution protein into cells for translation. He further presented data suggesting variability in spike protein expression among individuals, including Linard described laboratory findings indicating that spike protein isoforms may be produced due to glycosylation